Emil Kakkis, MD, PhD

PRESIDENT & CEO, ULTRAGENYX PHARMACEUTICAL INC.

Dr. Kakkis is best known for his work developing novel treatments for rare diseases and working on policy issues affecting rare and ultarare disease treatment. Emil is Chief Executive Officer, President and Founder of Ultragenyx, a company with four approved therapies for five rare diseases and multiple late-stage clinical programs. Dr. Kakkis has received numerous awards including the Life Science Leadership Pantheon award from California Life Sciences, a Lifetime Achievement Award from the National MPS Society, the Roscoe O Brady Award for innovation from the WORLD Symposium and the Henri Termeer Visionary Leader Award from BIO, the biotechnology industry organization.

Speakers